Novartis Pharmaceuticals Corporation
Novartis Pharmaceuticals Corporation received $41.3M in federal prime contract obligations in the 12 months ending Oct 5, 2026, up 163.9% from $15.6M the year before, and $45.5M since FY2022. Its largest customer is the Department of Veterans Affairs.
See 6 contracts ending in the next 18 months ↓Contractor details
- Unique Entity ID (UEI)
- NG61ZA8TADW3
- CAGE code
- 04520
- Headquarters
- East Hanover, NJ
- Business size
- Other Than Small Business
- Parent company
- Novartis Sanierungsstiftung (UEI YE3YG1FDWMC5)
As recorded on this UEI's most recent prime contract action in USAspending.gov. Confirm current registration and certifications in SAM.gov.
Obligations by fiscal year
Net prime contract obligations by federal fiscal year.
Markets where it ranks top 10
Agency and NAICS markets where this UEI is one of the ten largest primes in the latest 12 months.
Top agencies
Funding agencies ranked by obligations since FY2022.
| Funding agency | Latest 12 mo | Since FY2022 |
|---|---|---|
| Department of Veterans Affairs | $39.3M | $54.5M |
| Department of Defense | $4.5M | $4.9M |
| Department of Justice | $44K | $44K |
Top NAICS codes
Industry codes agencies recorded on this contractor's awards, since FY2022.
| NAICS | Industry | Latest 12 mo | Since FY2022 |
|---|---|---|---|
| 325412 | Pharmaceutical Preparation Manufacturing | $43.8M | $59.5M |
What it sells
Product and service codes (PSC) on this contractor's awards, since FY2022.
| PSC | Description | Since FY2022 |
|---|---|---|
| 6505 | Drugs and Biologicals | $58.4M |
| 6550 | In Vitro Diagnostic Substances, Reagents, Test Kits and Sets | $981K |
| Q517 | Pharmacy Services | $46K |
Contracts ending in the next 18 months
This contractor's largest awards whose current period of performance ends soon. Options and extensions often move these dates.
| Award | Agency | Obligated | Current end |
|---|---|---|---|
| 36C26226N0112 | Department of Veterans Affairs PLUVICTO AND LUTATHERA | $4.3M | Oct 31, 2026 |
| 36C25026N0310 | Department of Veterans Affairs RADIOPHARMACEUTICALS PLUVICTO / LUTATHERA | $2.4M | Dec 31, 2026 |
| 36C24426F0063 | Department of Veterans Affairs RADIOPHARMACEUTICALS-LUTATHERA AND PLUVICTO INJECTIONS | $2.0M | Dec 31, 2026 |
| 36C25726N0205 | Department of Veterans Affairs LU177 - PLUVICTO/LUTATHERA | $4.2M | Feb 6, 2027 |
| 36C24126F0136 | Department of Veterans Affairs PLUVICTO | $2.5M | Sep 29, 2027 |
| 36C26127N0063 | Department of Veterans Affairs PLUVICTO NDC: 69488-0010-61 | $4.1M | Sep 30, 2027 |
Recent awards
This contractor's newest prime contract awards, most recent first.
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| 36C26127N0063 | Department of Veterans Affairs PLUVICTO NDC: 69488-0010-61 | $4.1M | Oct 1, 2026 |
| 36C26127N0055 | Department of Veterans Affairs PLUVCITO NDC: 69488-0010-61 | $1.9M | Oct 1, 2026 |
| 36C25027N0038 | Department of Veterans Affairs PLUVICTO | $1.3M | Oct 1, 2026 |
| 36C26127F0023 | Department of Veterans Affairs LUTATHERA LU 177 DOTATE | $251K | Oct 1, 2026 |
| 36C24827N0026 | Department of Veterans Affairs NETSPOT - GA-68 DOTATATE | $161K | Oct 1, 2026 |
| 36C24126F0136 | Department of Veterans Affairs PLUVICTO | $2.5M | Sep 30, 2026 |
| 36C25526N0394 | Department of Veterans Affairs PLUVICTO SUPPLIES | $892K | Aug 24, 2026 |
| 36C26226F0314 | Department of Veterans Affairs PLUVICTO DELIVERY ORDER | $823K | Jul 17, 2026 |
Prime contracts (award types A–D) from USAspending.gov through Oct 5, 2026. Subcontracts are not included. Net obligations include deobligations and corrections.
Ready to connect your pursuit work?
GovEagle gives BD directors, capture managers, and proposal teams one AI workspace from pipeline through proposal, with CMMC/FedRAMP Certified compliance built in.